| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/14/2022 | 8.26% | Truist Securities | $140 → $150 | Maintains | Hold |
| 08/15/2022 | 9.7% | Compass Point | → $152 | Upgrades | Neutral → Buy |
| 08/02/2022 | 4.65% | Stephens & Co. | $133 → $145 | Maintains | Equal-Weight |
| 08/01/2022 | 1.76% | Wedbush | → $141 | Upgrades | Underperform → Neutral |
| 07/29/2022 | 8.26% | Raymond James | $145 → $150 | Maintains | Outperform |
| 07/13/2022 | -7.62% | Compass Point | → $128 | Upgrades | Sell → Neutral |
| 07/07/2022 | 4.65% | Raymond James | $160 → $145 | Maintains | Outperform |
| 06/15/2022 | 11.86% | JP Morgan | $143 → $155 | Upgrades | Underweight → Overweight |
| 06/13/2022 | -3.29% | Truist Securities | $149 → $134 | Maintains | Hold |
| 05/26/2022 | -4.73% | Wolfe Research | $161 → $132 | Maintains | Outperform |
| 04/07/2022 | 23.41% | Wolfe Research | $157 → $171 | Upgrades | Underperform → Outperform |
| 04/06/2022 | 15.47% | Raymond James | → $160 | Upgrades | Market Perform → Outperform |
| 01/28/2022 | — | Raymond James | Upgrades | Underperform → Market Perform | |
| 12/06/2021 | -22.06% | Morgan Stanley | $100 → $108 | Maintains | Underweight |
| 11/01/2021 | -27.83% | Morgan Stanley | $96 → $100 | Maintains | Underweight |
| 10/29/2021 | -2.57% | RBC Capital | $126 → $135 | Maintains | Sector Perform |
| 10/29/2021 | -3.29% | Stephens & Co. | $120 → $134 | Maintains | Equal-Weight |
| 10/01/2021 | -6.18% | Truist Securities | $117 → $130 | Maintains | Hold |
| 05/04/2021 | -30.72% | Morgan Stanley | $90 → $96 | Maintains | Underweight |
| 05/03/2021 | -3.29% | Truist Securities | $111 → $134 | Maintains | Hold |
| 03/18/2021 | -35.05% | Morgan Stanley | $85 → $90 | Maintains | Underweight |
| 03/08/2021 | -19.89% | Truist Securities | $96 → $111 | Maintains | Hold |
| 02/24/2021 | -38.65% | Morgan Stanley | $81 → $85 | Maintains | Underweight |
| 01/07/2021 | -41.54% | Morgan Stanley | $75 → $81 | Maintains | Underweight |
| 12/07/2020 | -45.87% | Morgan Stanley | $64 → $75 | Maintains | Underweight |
| 11/12/2020 | -42.26% | Keefe, Bruyette & Woods | → $80 | Downgrades | Outperform → Market Perform |
| 11/11/2020 | -48.76% | Compass Point | $69 → $71 | Downgrades | Neutral → Sell |
| 11/03/2020 | -53.81% | Morgan Stanley | $65 → $64 | Maintains | Underweight |
| 06/08/2020 | -53.09% | Morgan Stanley | $63 → $65 | Maintains | Underweight |
| 05/18/2020 | -56.7% | CFRA | $91 → $60 | Maintains | Sell |
| 05/01/2020 | -43.71% | SunTrust Robinson Humphrey | $64 → $78 | Maintains | Hold |
| 05/01/2020 | -56.7% | B of A Securities | $53 → $60 | Reiterates | → Underperform |
| 04/07/2020 | -54.53% | Morgan Stanley | $72 → $63 | Maintains | Underweight |
| 03/17/2020 | -48.04% | Morgan Stanley | $78 → $72 | Maintains | Underweight |
| 03/09/2020 | -43.71% | Morgan Stanley | $82 → $78 | Maintains | Underweight |
| 03/06/2020 | -42.26% | SunTrust Robinson Humphrey | $104 → $80 | Downgrades | Buy → Hold |
| 03/05/2020 | -40.82% | Morgan Stanley | $89 → $82 | Maintains | Underweight |
| 02/13/2020 | -29.99% | Stephens & Co. | $104 → $97 | Maintains | Equal-Weight |
| 01/31/2020 | — | Evercore ISI Group | Downgrades | In-Line → Underperform | |
| 11/04/2019 | -35.77% | Morgan Stanley | $92 → $89 | Maintains | Underweight |
| 11/01/2019 | — | Wedbush | Downgrades | Neutral → Underperform | |
| 10/03/2019 | -33.6% | Morgan Stanley | $94 → $92 | Maintains | Underweight |
| 09/16/2019 | -24.22% | SunTrust Robinson Humphrey | $108 → $105 | Maintains | Buy |
| 07/11/2019 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 04/26/2019 | -31.44% | Wedbush | $94 → $95 | Maintains | Neutral |
| 01/10/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 12/11/2018 | -28.55% | Morgan Stanley | $103 → $99 | Maintains | Underweight |
| 11/12/2018 | -25.66% | Morgan Stanley | $105 → $103 | Downgrades | Equal-Weight → Underweight |
| 10/29/2018 | -24.22% | SunTrust Robinson Humphrey | $124 → $105 | Maintains | Buy |
| 09/18/2018 | -17% | Morgan Stanley | $116 → $115 | Maintains | Equal-Weight |
| 05/04/2018 | -15.56% | Deutsche Bank | $108 → $117 | Maintains | Hold |
| 04/30/2018 | -17% | Morgan Stanley | $107 → $115 | Maintains | Equal-Weight |
| 04/27/2018 | -13.39% | Barclays | $113 → $120 | Maintains | Equal-Weight |
| 04/27/2018 | — | B of A Securities | Upgrades | Underperform → Buy | |
| 04/27/2018 | -9.79% | Maxim Group | $120 → $125 | Maintains | Buy |
| 04/10/2018 | — | Raymond James | Downgrades | Market Perform → Underperform | |
| 01/26/2018 | -18.45% | Barclays | $110 → $113 | Maintains | Equal-Weight |
| 01/26/2018 | -13.39% | Maxim Group | $110 → $120 | Reiterates | Buy → Buy |
| 12/13/2017 | -22.78% | Morgan Stanley | $96 → $107 | Maintains | Equal-Weight |
| 11/08/2017 | -26.39% | Deutsche Bank | $96 → $102 | Maintains | Hold |
| 10/30/2017 | -23.5% | Barclays | $97 → $106 | Maintains | Equal-Weight |
| 10/30/2017 | -34.32% | JP Morgan | $88 → $91 | Maintains | Neutral |
| 10/27/2017 | — | Raymond James | Upgrades | Underperform → Market Perform |
Cullen/Frost Bankers Questions & Answers
The latest price target for Cullen/Frost Bankers (NYSE: CFR) was reported by Truist Securities on September 14, 2022. The analyst firm set a price target for $150.00 expecting CFR to rise to within 12 months (a possible 8.26% upside). 18 analyst firms have reported ratings in the last year.
The latest analyst rating for Cullen/Frost Bankers (NYSE: CFR) was provided by Truist Securities, and Cullen/Frost Bankers maintained their hold rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cullen/Frost Bankers, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cullen/Frost Bankers was filed on September 14, 2022 so you should expect the next rating to be made available sometime around September 14, 2023.
While ratings are subjective and will change, the latest Cullen/Frost Bankers (CFR) rating was a maintained with a price target of $140.00 to $150.00. The current price Cullen/Frost Bankers (CFR) is trading at is $138.56, which is out of the analyst's predicted range.